SNCA and Alzheimer disease: The maximum Youden index which describes the performance of a diagnostic test/biomarker was used to determine the potentially optimal anti-α-synuclein IgG cut-off level, marked by a star in Fig. 5A and Fig. 5B, to separate AD or DLB patients from controls.